Rigel Pharmaceuticals | RIGL - Trade Debtors

Stock Price
29.48
Daily Change
-0.15 -0.51%
Monthly
-13.68%
Yearly
49.64%
Q1 Forecast
33.68

Rigel Pharmaceuticals reported $28.9M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
Agenus USD 354K 53K Mar/2025
Amgen USD 9.57B 1.08B Dec/2025
Anika Therapeutics USD 21.99M 1.61M Mar/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Celldex Therapeutics USD 2.02M 1.92M Dec/2025
Daiichi Sankyo JPY 695.95B 79.1B Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Halozyme Therapeutics USD 441.27M 95.24M Dec/2025
Heron Therapeutics USD 67.04M 6.9M Sep/2024
Intrexon USD 1.02M 559K Jun/2024
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
Karyopharm Therapeutics USD 31.78M 6.82M Sep/2024
Ligand Pharmaceuticals USD 58.1M 15.98M Sep/2025
MacroGenics USD 69.23M 56.7M Sep/2025
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Sangamo BioSciences USD 581K 110K Jun/2024
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Veracyte USD 44.66M 3.17M Dec/2025